Summary by Moomoo AI
On July 17, 2024, Three-Leaf Bio-Pharmaceutical Co., Ltd. ("Trifolium Bio-B") resubmitted its Securities Statement of Changes in Equity for the month ended April 30, 2024. The report shows that the company's statutory/registered capital is maintained at 2,000,000,000 shares with a par value of $0.0001 per share, totaling $200,000. The number of issued shares (excluding treasury shares) increased from 1,296,995,429 shares at the end of last month to 1,297,047,429 shares, an increase of 52,000 shares. The increase is due to the exercise of stock options this month, resulting in the addition of 52,000 common shares, while 92,000 stock options have become invalid. A total of 6,993,573 stock options became invalid after the initial public offering. The company confirms that all securities issuance has been authorized by the board of directors and complies with relevant listing rules and regulations.
